Your browser doesn't support javascript.
The COVID-19 vaccination acceptance/hesitancy rate and its determinants among healthcare workers of 91 Countries: A multicenter cross-sectional study.
Askarian, Mehrdad; Semenov, Aleksandr; Llopis, Ferran; Rubulotta, Francesca; Dragovac, Gorana; Pshenichnaya, Natalia; Assadian, Ojan; Ruch, Yvon; Shayan, Zahra; Padilla Fortunatti, Cristobal; Lucey, Daniel; Almohaizeie, Abdullah; Kamal, Abu Hena Mostafa; Ogunshe, Adenike; Konkayev, Aidos; Beg, Asim; Primerano, Enzo; Amer, Fatma; Kumari Pilli, Hema Prakash; Hung, Ivan; Ayoade, Folusakin; Lefrant, Jean Yves; Zajkowska, Joanna; Rello, Jordi; Kazi, Momin; Taghrir, Mohammad Hossein; Blot, Stijn; Leib, Stephen; Hosseinpour, Parisa; Hosseinpour, Hamidreza; Erfani, Amirhossein; Borazjani, Roham; Akbarialiabad, Hossein; Najafi, Masoud; Askarian, Ardalan; Erdem, Hakan.
  • Askarian M; Department of Community Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran; Health Behavior Science Research Center, Shiraz University of Medical Sciences, Shiraz.
  • Semenov A; Ekaterinburg Research Institute of Viral Infections SRC VB Vector, Ekaterinburg, Russia.
  • Llopis F; Emergency Department. Bellvitge University Hospital, l'Hospitalet de Llobregat, Barcelona, Spain.
  • Rubulotta F; Department of Intensive Care Medicine, Charing Cross Hospital, Imperial College, NHS Trust London, UK.
  • Dragovac G; Department of Epidemiology, Faculty of Medicine, University of Novi Sad, Serbia; Center of Disease Prevention and Control, Institute of Public Health of Vojvodina, Novi Sad, Serbia.
  • Pshenichnaya N; Clinical Department of Infectious Pathology, Central Research Institute of Epidemiology, Moscow, Russia.
  • Assadian O; Regional Hospital Wiener Neustadt, Austria; Institute of Skin Integrity and Infection Prevention, University of Huddersfield, UK.
  • Ruch Y; Department of Infectious Diseases, Strasbourg University Hospital, Strasbourg, France.
  • Shayan Z; Trauma Research Center, Department of Biostatistics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Padilla Fortunatti C; School of Nursing, Pontificia Universidad Catolica de Chile, Santiago, Chile.
  • Lucey D; Department of Infectious Diseases, Georgetown University Medical Center, Washington, DC 20057, USA.
  • Almohaizeie A; King Faisal Specialist Hospital and Research Center, Riyadh, Alfaisal University Riyadh, Saudi Arabia.
  • Kamal AHM; Department of Anaesthesiology & ICU, Rajshahi Medical College Hospital, Rajshahi, Bangladesh.
  • Ogunshe A; Applied Microbiology and Infectious Diseases, Department of Microbiology, Faculty of Science, University of Ibadan, Oyo State, Nigeria.
  • Konkayev A; Department of Anesthesiology and Intensive Care, Astana Medical University, Nur-Sultan, Kazakhstan; National Centre of Traumatology and Orthopedia named by Batpenov, Nur-Sultan, Kazakhstan.
  • Beg A; Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan.
  • Primerano E; Department of Anesthesia and Intensive Care, Polyclinic of Monza, Monza, Italy.
  • Amer F; Department of Medical Microbiology and Immunology, School of Medicine, Zagazig University, Zagazig, Egypt.
  • Kumari Pilli HP; Department of Microbiology, GITAM Institute of Medical Sciences and Research, GITAM , Deemed to be University, Visakhapatnam, India.
  • Hung I; Department of Infectious Diseases; Gastroenterology & Hepatology, The University of Hong Kong.
  • Ayoade F; Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Lefrant JY; Department of Anaesthesia, Critical Care Emergency and Pain Medicine, University Hospital of Nimes, Montpellier University, Nimes, France.
  • Zajkowska J; Department of Infectious Diseases and Neuroinfections, Medical University in Biaøystok, Poland.
  • Rello J; CRIPS, Vall Hebron Institute of Research (VHIR) & CHRU Nimes, Nimes, France.
  • Kazi M; Research Department of Paediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
  • Taghrir MH; Trauma Research Center, Shahid Rajaee (Emtiaz) Trauma Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Blot S; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
  • Leib S; Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
  • Hosseinpour P; School of Medicine, Islamic Azad University, Kazeroun branch, Kazeroun, Iran.
  • Hosseinpour H; Department of Surgery, Shiraz Laparoscopic Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Erfani A; Thoracic and Vascular Surgery Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Borazjani R; Trauma Research Center, Shahid Rajaee (Emtiaz) Trauma Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Akbarialiabad H; Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Najafi M; Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Askarian A; Student, College of Arts & Science, University of Saskatchewan, Saskatoon, Canada.
  • Erdem H; ID-IRI Lead Coordinator, Ankara, Turkey.
EXCLI J ; 21: 93-103, 2022.
Article in English | MEDLINE | ID: covidwho-1667813
ABSTRACT
The aim of this study was to investigate the COVID-19 vaccination acceptance rate and its determinants among healthcare workers in a multicenter study. This was a cross-sectional multi-center survey conducted from February 5 to April 29, 2021. The questionnaire consisted of 26 items in 6 subscales. The English version of the questionnaire was translated into seven languages and distributed through Google Forms using snowball sampling; a colleague in each country was responsible for the forward and backward translation, and also the distribution of the questionnaire. A forward stepwise logistic regression was utilized to explore the variables and questionnaire factors tied to the intention to COVID-19 vaccination. 4630 participants from 91 countries completed the questionnaire. According to the United Nations Development Program 2020, 43.6 % of participants were from low Human Development Index (HDI) regions, 48.3 % high and very high, and 8.1 % from medium. The overall vaccination hesitancy rate was 37 %. Three out of six factors of the questionnaire were significantly related to intention to the vaccination. While 'Perceived benefits of the COVID-19 vaccination' (OR 3.82, p-value<0.001) and 'Prosocial norms' (OR 5.18, p-value<0.001) were associated with vaccination acceptance, 'The vaccine safety/cost concerns' with OR 3.52, p-value<0.001 was tied to vaccination hesitancy. Medical doctors and pharmacists were more willing to take the vaccine in comparison to others. Importantly, HDI with OR 12.28, 95 % CI 6.10-24.72 was a strong positive determinant of COVID-19 vaccination acceptance. This study highlighted the vaccination hesitancy rate of 37 % in our sample among HCWs. Increasing awareness regarding vaccination benefits, confronting the misinformation, and strengthening the prosocial norms would be the primary domains for maximizing the vaccination coverage. The study also showed that the HDI is strongly associated with the vaccination acceptance/hesitancy, in a way that those living in low HDI contexts are more hesitant to receive the vaccine.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Vaccines Language: English Journal: EXCLI J Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Vaccines Language: English Journal: EXCLI J Year: 2022 Document Type: Article